Peptide Inhibitors for Selective MMP-1, 2, and 9 Blocking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for addressing MMP overexpression or increased MMP activity in skin, mucosae, and scalp conditions are inadequate, as existing MMP inhibitors are not effective enough or selective enough, leading to unresolved skin and scalp pathologies such as aging, acne, rosacea, and hair loss.
Innovation Solution
Development of specific peptides with a general formula (R1-AA1-AA2-AA3-AA4-R2) that inhibit human MMP-1, MMP-2, and MMP-9, which are applied topically or orally to treat and care for skin, mucosae, and scalp conditions by mimicking natural MMP inhibitors like TIMPs, but with a distinct amino acid sequence not found in natural products.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing MMP inhibitors are used, then some MMP activity is inhibited, but they are not selective enough and lack sufficient efficacy
Solution Approach 1:
The patent applies local quality by designing peptides with specific amino acid sequences (AA1-AA2-AA3-AA4) that are tailored to bind to particular MMP active sites. Each position in the peptide sequence can be optimized to interact with specific residues in the target MMP, providing selective inhibition for MMP-1, MMP-2, or MMP-9 while sparing other MMPs. This localized optimization of binding interactions at the molecular level achieves both high efficacy and selectivity simultaneously.
Solution Approach 2:
The patent employs parameter changes by systematically varying the amino acid composition, sequence, and structural properties of the inhibitor peptides. By changing parameters such as hydrophobicity, charge distribution, and steric properties at different positions in the peptide sequence, the invention optimizes both the binding affinity (efficacy) and the specificity (selectivity) for target MMPs. This parametric optimization allows fine-tuning of the inhibition profile to achieve superior performance compared to existing inhibitors.
2Reliability
If natural MMP inhibitors like TIMPs are mimicked, then biological compatibility is improved, but the amino acid sequence is identical to natural products
Solution Approach 1:
The patent applies copying by creating synthetic peptide sequences that replicate the functional characteristics and binding mode of natural TIMPs without copying their exact amino acid sequences. The invention captures the essential structural features and interaction mechanisms of TIMPs (such as the hemi-thioether bond formation and zinc coordination) while using different amino acid compositions. This functional copying achieves biological compatibility through mechanism mimicry rather than sequence identity, enabling both natural product-like behavior and structural distinction.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptides effectively inhibit MMPs, providing a simple and risk-free solution for treating and caring for conditions related to MMP overexpression, thereby delaying or preventing skin and scalp pathologies like aging, acne, and hair loss, while offering improved selectivity and efficacy compared to existing compounds.
Implementation Method 1
peptides capable of inhibiting the activity of matrix metalloproteinases (MMP)
Data Source
AI summary
Peptides of general formula (I): R1AA1-AA2-AA3-AA4-R2 stereoisomers thereof, mixtures thereof or the cosmetically or pharmaceutically acceptable salts thereof, a method for obtaining them, cosmetic or pharmaceutical compositions containing them, and their use for the treatment and/or care of those conditions, disorders and/or pathologies of the skin, mucosae and/or scalp resulting from matrix metalloproteinases (MMP) overexpression or an increase in the MMP activity.